3 results
This is an open-label, non-randomized, multicentre phase II study with an initial safety-run in. During the safety run-in phase, we will investigate the safety of combining IMM-101 administration with SBRT in 20 patients with limited metastatic…
To investigate the feasibility of skin perfusion measurements of lower limb tissue in 20 PAOD patients with continuous ICG-VA. Feasibility is defined as the ability to detect hypo perfusion in the diseased leg in comparison with the patient's…
We hypothesize that a significant proportion of the patients will benefit more from focal therapy as compared to usual care in terms of morbidity and quality of life, without compromising oncological effectiveness. Primary objective: To study the…